Description

Enoxaparin Solution for Injections 10000 anti-Cha IU/ml. 3 ml. Vial №1

Ingredients:

Enoxaparin solution for injections contains 10000 anti-Cha IU/ml as the active ingredient.

Dosage:

The recommended dosage of Enoxaparin solution for injections should be determined by a healthcare professional based on the patient’s condition. It is usually administered subcutaneously once or twice daily.

Indications:

Enoxaparin is indicated for the prevention of deep vein thrombosis (DVT) in patients undergoing certain surgeries and for the treatment of DVT and pulmonary embolism.

Contraindications:

Do not use Enoxaparin solution for injections if the patient has active major bleeding, a history of heparin-induced thrombocytopenia, or hypersensitivity to enoxaparin.

Directions:

Administer the injection subcutaneously into the abdomen, alternating sides with each dose. Do not rub the injection site.

Scientific Evidence:

Enoxaparin is a low molecular weight heparin that has been extensively studied for its efficacy and safety in preventing and treating thromboembolic disorders. Clinical trials have demonstrated the effectiveness of enoxaparin in reducing the risk of DVT and pulmonary embolism compared to unfractionated heparin.

Additional Information:

It is important to monitor for signs of bleeding while using Enoxaparin solution for injections. Patients should be educated on the proper administration technique to minimize the risk of complications.

Pharmacological Effects: Enoxaparin works by inhibiting the activity of factor Xa, a key enzyme in the coagulation cascade. This anticoagulant effect helps prevent the formation of blood clots.

Comparative Effectiveness: Studies have shown that enoxaparin is as effective as unfractionated heparin in preventing thromboembolic events with a lower risk of heparin-induced thrombocytopenia.